{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T09:55:15Z","timestamp":1777629315298,"version":"3.51.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"DOI":"10.1007\/s00280-026-04893-x","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T02:19:38Z","timestamp":1777429178000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Homoharringtonine suppresses gastric cancer progression by targeting PI3K\/ AKT\/FOXO pathway and impairing the GSH\u2013GPX4 antioxidant axis"],"prefix":"10.1007","volume":"96","author":[{"given":"Xiaonan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Ying","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunyuan","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanshan","family":"Ru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haonan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingzhe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingjing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"key":"4893_CR1","first-page":"394","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394\u2013424","journal-title":"CA Cancer J Clin"},{"key":"4893_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.semcancer.2022.05.001","volume":"86","author":"E Bess\u00e8de","year":"2022","unstructured":"Bess\u00e8de E, M\u00e9graud F (2022) Microbiota and gastric cancer. Sem Cancer Biol 86:11\u201317","journal-title":"Sem Cancer Biol"},{"key":"4893_CR3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13045-023-01451-3","volume":"16","author":"WL Guan","year":"2023","unstructured":"Guan WL, He Y, Xu RH (2023) Gastric cancer treatment: recent progress and future perspectives. J Hematol Oncol 16:57","journal-title":"J Hematol Oncol"},{"key":"4893_CR4","doi-asserted-by":"publisher","first-page":"pbae020","DOI":"10.1093\/pcmedi\/pbae020","volume":"7","author":"M Yang","year":"2024","unstructured":"Yang M, Lin W, Huang J, Mannucci A, Luo H (2024) Novel immunotherapeutic approaches in gastric cancer. Precision Clin Med 7:pbae020","journal-title":"Precision Clin Med"},{"key":"4893_CR5","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1158\/2159-8290.CD-21-0219","volume":"11","author":"M Kwon","year":"2021","unstructured":"Kwon M, An M, Klempner SJ, Lee H, Kim KM, Sa JK, Cho HJ, Hong JY, Lee T, Min YW, Kim TJ, Min BH, Park WY, Kang WK, Kim KT, Kim ST, Lee J (2021) Determinants of Response and Intrinsic Resistance to PD-1 Blockade in Microsatellite Instability-High Gastric Cancer. Cancer Discov 11:2168\u20132185","journal-title":"Cancer Discov"},{"key":"4893_CR6","first-page":"e2300898","volume":"10","author":"Q Yang","year":"2023","unstructured":"Yang Q, Lei X, He J, Peng Y, Zhang Y, Ling R, Wu C, Zhang G, Zheng B, Chen X, Zou B, Fu Z, Zhao L, Liu H, Hu Y, Yu J, Li F, Ye G, Li G (2023) N4-Acetylcytidine Drives Glycolysis Addiction in Gastric Cancer via NAT10\/SEPT9\/HIF-1\u03b1 Positive Feedback Loop. Adv Sci (Weinheim Baden-Wurttemberg Germany) 10:e2300898","journal-title":"Adv Sci (Weinheim Baden-Wurttemberg Germany)"},{"key":"4893_CR7","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/1479-5876-11-265","volume":"11","author":"M Zhou","year":"2013","unstructured":"Zhou M, Zeng J, Wang X, Guo Q, Huang T, Shen H, Fu Y, Wang L, Jia J, Chen C (2013) MiR-370 sensitizes chronic myeloid leukemia K562 cells to homoharringtonine by targeting Forkhead box M1. J translational Med 11:265","journal-title":"J translational Med"},{"key":"4893_CR8","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.clml.2013.03.017","volume":"13","author":"HM Kantarjian","year":"2013","unstructured":"Kantarjian HM, O\u2019Brien S, Cortes J (2013) Homoharringtonine\/omacetaxine mepesuccinate: the long and winding road to food and drug administration approval. Clin lymphoma myeloma Leuk 13:530\u2013533","journal-title":"Clin lymphoma myeloma Leuk"},{"key":"4893_CR9","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1182\/blood.2023023400","volume":"144","author":"S Suo","year":"2024","unstructured":"Suo S, Zhao D, Li F, Zhang Y, Rodriguez-Rodriguez S, Nguyen LXT, Ghoda L, Carlesso N, Marcucci G, Zhang B, Jin J (2024) Homoharringtonine inhibits the NOTCH\/MYC pathway and exhibits antitumor effects in T-cell acute lymphoblastic leukemia. Blood 144:1343\u20131347","journal-title":"Blood"},{"key":"4893_CR10","doi-asserted-by":"publisher","first-page":"6644","DOI":"10.1002\/jcb.26847","volume":"119","author":"L Wang","year":"2018","unstructured":"Wang L, Zhao L, Wei G, Saur D, Seidler B, Wang J, Wang C, Qi T (2018) Homoharring-tonine could induce quick protein synthesis of PSMD11 through activating MEK1\/ERK1\/2 signaling pathway in pancreatic cancer cells. J Cell Biochem 119:6644\u20136656","journal-title":"J Cell Biochem"},{"key":"4893_CR11","doi-asserted-by":"publisher","first-page":"995","DOI":"10.7150\/ijbs.44907","volume":"17","author":"LB Wang","year":"2021","unstructured":"Wang LB, Wang DN, Wu LG, Cao J, Tian JH, Liu R, Ma R, Yu JJ, Wang J, Huang Q, Xiong WY, Zhang X (2021) Homoharringtonine inhibited breast cancer cells growth via miR-18a-3p\/AKT\/mTOR signaling pathway. Int J Biol Sci 17:995\u20131009","journal-title":"Int J Biol Sci"},{"key":"4893_CR12","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1186\/s12935-024-03448-5","volume":"24","author":"Y Cheng","year":"2024","unstructured":"Cheng Y, Lu Y, Xue J, Wang X, Zhou L, Luo Y, Li Y (2024) DDX19A promotes gastric cancer cell proliferation and migration by activating the PI3K\/AKT pathway. Cancer Cell Int 24:272","journal-title":"Cancer Cell Int"},{"key":"4893_CR13","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12943-024-02016-9","volume":"23","author":"H Wei","year":"2024","unstructured":"Wei H, Li W, Zeng L, Ding N, Li K, Yu H, Jiang F, Yin H, Xia Y, Deng C, Cai N, Chen X, Gu L, Chen H, Zhang F, He Y, Li J, Zhang C (2024) OLFM4 promotes the progression of intestinal metaplasia through activation of the MYH9\/GSK3\u03b2\/\u03b2-catenin pathway. Mol Cancer 23:124","journal-title":"Mol Cancer"},{"key":"4893_CR14","doi-asserted-by":"publisher","first-page":"eadk0330","DOI":"10.1126\/scitranslmed.adk0330","volume":"16","author":"HL Zhang","year":"2024","unstructured":"Zhang HL, Hu BX, Ye ZP, Li ZL, Liu S, Zhong WQ, Du T, Yang D, Mai J, Li LC, Chen YH, Zhu XY, Li X, Feng GK, Zhu XF, Deng R (2024) TRPML1 triggers ferroptosis defense and is a potential therapeutic target in AKT-hyperactivated cancer. Sci Transl Med 16:eadk0330","journal-title":"Sci Transl Med"},{"key":"4893_CR15","doi-asserted-by":"crossref","unstructured":"Zang F, Rao Y, Zhu X, Wu Z, Jiang H (2020) Shikonin suppresses NEAT1 and Akt signalling in treating paclitaxel-resistant non-small cell of lung cancer. Molecular medicine (Cambridge, Mass.), ;26: 28","DOI":"10.1186\/s10020-020-00152-8"},{"key":"4893_CR16","doi-asserted-by":"crossref","unstructured":"Kim SH, Seung BJ, Cho SH, Lim HY, Bae MK, Sur JH (2021) Dysregulation of PI3K\/Akt\/PTEN Pathway in Canine Mammary Tumour. Animals: an open access journal from MDPI, ;11: 2079","DOI":"10.3390\/ani11072079"},{"key":"4893_CR17","doi-asserted-by":"publisher","first-page":"155360","DOI":"10.1016\/j.phymed.2024.155360","volume":"128","author":"M Chen","year":"2024","unstructured":"Chen M, Li H, Zheng S, Shen J, Chen Y, Li Y, Yuan M, Wu J, Sun Q (2024) Nobiletin targets SREBP1\/ACLY to induce autophagy-dependent cell death of gastric cancer cells through PI3K\/Akt\/mTOR signaling pathway. Phytomedicine: Int J phytotherapy phytopharmacology 128:155360","journal-title":"Phytomedicine: Int J phytotherapy phytopharmacology"},{"key":"4893_CR18","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1007\/s10495-023-01855-z","volume":"28","author":"G Chen","year":"2023","unstructured":"Chen G, Zhang H, Sun H, Ding X, Liu G, Yang F, Feng G, Dong X, Zhu Y, Wang X, Wang Y, Li B, Yang L (2023) Bufalin targeting BFAR inhibits the occurrence and metastasis of gastric cancer through PI3K\/AKT\/mTOR signal pathway. Apoptosis: Int J Program cell death 28:1390\u20131405","journal-title":"Apoptosis: Int J Program cell death"},{"key":"4893_CR19","doi-asserted-by":"crossref","unstructured":"Park A, Joo M, Kim K, Son WJ, Lim G, Lee J, Kim JH, Lee DH, Nam S (2022) A comprehensive evaluation of regression-based drug responsiveness prediction models, using cell viability inhibitory concentrations (IC50 values). Bioinformatics (Oxford, England), ;38: 2810\u20132817","DOI":"10.1093\/bioinformatics\/btac177"},{"key":"4893_CR20","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/vco.12948","volume":"22","author":"X Zhang","year":"2024","unstructured":"Zhang X, Mei C, Liang Z, Zhi Y, Xu H, Wang H, Dong H (2024) Homoharringtonine induces apoptosis of mammary carcinoma cells by inhibiting the AKT\/mTOR signaling pathway. Vet Comp Oncol 22:57\u201369","journal-title":"Vet Comp Oncol"},{"issue":"1","key":"4893_CR21","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S (2000) KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28(1):27\u201330. https:\/\/doi.org\/10.1093\/nar\/28.1.27","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"4893_CR22","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1101\/gr.6202607","volume":"17","author":"S Draghici","year":"2007","unstructured":"Draghici S, Khatri P, Tarca AL, Amin K, Done A, Voichita C, Georgescu C, Romero R (2007) A systems biology approach for pathway level analysis. Genome Res 17(10):1537\u20131545. https:\/\/doi.org\/10.1101\/gr.6202607","journal-title":"Genome Res"},{"issue":"4","key":"4893_CR23","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.7150\/ijbs.80324","volume":"19","author":"C Hu","year":"2023","unstructured":"Hu C, Zu D, Xu J, Xu H, Yuan L, Chen J, Wei Q, Zhang Y, Han J, Lu T, Dong J, Qin JJ, Xu Z, Cheng X (2023) Polyphyllin B Suppresses Gastric Tumor Growth by Modulating Iron Metabolism and Inducing Ferroptosis. Int J Biol Sci 19(4):1063\u20131079","journal-title":"Int J Biol Sci"},{"issue":"4","key":"4893_CR24","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/s41401-021-00729-x","volume":"43","author":"YQ Tang","year":"2022","unstructured":"Tang YQ, Li ZW, Feng YF, Yang HQ, Hou CL, Geng C, Yang PR, Zhao HM, Wang J (2022) MK2206 attenuates atherosclerosis by inhibiting lipid accumulation, cell migration, proliferation, and inflammation. Acta Pharmacol Sin 43(4):897\u2013907","journal-title":"Acta Pharmacol Sin"},{"issue":"43","key":"4893_CR25","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK et al (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102(43):15545\u201315550. https:\/\/doi.org\/10.1073\/pnas.0506580102","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"4893_CR26","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1016\/j.bbagen.2012.09.008","volume":"1830","author":"SC Lu","year":"2013","unstructured":"Lu SC (2013) Glutathione synthesis. Biochim Biophys Acta 1830(5):3143\u20133153. https:\/\/doi.org\/10.1016\/j.bbagen.2012.09.008","journal-title":"Biochim Biophys Acta"},{"key":"4893_CR27","first-page":"307","volume":"509","author":"WS Yang","year":"2014","unstructured":"Yang WS, SriRamaratnam R, Welsch ME, Shimada K, Skouta R, Viswanathan VS, Cheah JH, Clemons PA, Shamji AF, Clish CB, Brown LM, Girotti AW, Gray NS, Ratinov G et al (2014) Regul ferroptotic cancer cell death GPX4 Nat 509:307\u2013311","journal-title":"Regul ferroptotic cancer cell death GPX4 Nat"},{"issue":"12","key":"4893_CR28","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.3390\/antiox14121411","volume":"14","author":"I Artusi","year":"2025","unstructured":"Artusi I, Rubin M, Cravin G, Cozza G (2025) Ferroptosis in Human Diseases: Fundamental Roles and Emerging Therapeutic Perspectives. Antioxid (Basel) 14(12):1411 Published 2025 Nov 26. https:\/\/doi.org\/10.3390\/antiox14121411","journal-title":"Antioxid (Basel)"},{"key":"4893_CR29","doi-asserted-by":"publisher","first-page":"120266","DOI":"10.1016\/j.lfs.2021.120266","volume":"290","author":"M Xu","year":"2022","unstructured":"Xu M, Ren L, Fan J, Huang L, Zhou L, Li X, Ye X (2022) Berberine inhibits gastric cancer development and progression by regulating the JAK2\/STAT3 pathway and downregulating IL-6. Life Sci 290:120266","journal-title":"Life Sci"},{"issue":"5","key":"4893_CR30","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.ajpath.2018.01.013","volume":"188","author":"W Liu","year":"2018","unstructured":"Liu W, Jing ZT, Wu SX, He Y, Lin YT, Chen WN, Lin XJ, Lin XA, Novel AKT, Activator (2018) SC79, Prevents Acute Hepatic Failure Induced by Fas-Mediated Apoptosis of Hepatocytes. Am J Pathol 188(5):1171\u20131182","journal-title":"Am J Pathol"},{"key":"4893_CR31","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","volume":"396","author":"EC Smyth","year":"2020","unstructured":"Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F (2020) Gastric cancer. Lancet (London England) 396:635\u2013648","journal-title":"Lancet (London England)"},{"key":"4893_CR32","doi-asserted-by":"crossref","unstructured":"Ajani, J. A., D\u2019Amico, T. A., Bentrem, D. J., Chao, J., Cooke, D., Corvera, C., Das,P., Enzinger, P. C., Enzler, T., Fanta, P., Farjah, F., Gerdes, H., Gibson, M. K.,Hochwald, S., Hofstetter, W. L., Ilson, D. H., Keswani, R. N., Kim, S., Kleinberg,L. R., Klempner, S. J., \u2026 Pluchino, L. A. Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network:JNCCN, 2022;20: 167\u2013192.","DOI":"10.6004\/jnccn.2022.0008"},{"key":"4893_CR33","doi-asserted-by":"crossref","unstructured":"Kang, Y. K., Boku, N., Satoh, T., Ryu, M. H., Chao, Y., Kato, K., Chung, H. C., Chen,J. S., Muro, K., Kang, W. K., Yeh, K. H., Yoshikawa, T., Oh, S. C., Bai, L. Y., Tamura,T., Lee, K. W., Hamamoto, Y., Kim, J. G., Chin, K., Oh, D. Y., \u2026 Chen, L. T. Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2):a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet (London, England),2017;390: 2461\u20132471.","DOI":"10.1016\/S0140-6736(17)31827-5"},{"key":"4893_CR34","doi-asserted-by":"crossref","unstructured":"Catenacci D. V., Tesfaye A, Tejani M, Cheung E, Eisenberg P., Scott A. J., Eng C, Hnatyszyn J, Marina N, Powers J, Wainberg Z. (2019) Bemarituzumab with modified FOLFOX6 for advanced FGFR2-positive gastroesophageal cancer: FIGHT Phase III study design. Future Oncol (London England) 15:2073\u20132082","DOI":"10.2217\/fon-2019-0141"},{"key":"4893_CR35","doi-asserted-by":"publisher","first-page":"FSO721","DOI":"10.2144\/fsoa-2021-0023","volume":"7","author":"H Shoji","year":"2021","unstructured":"Shoji H, Takahari D, Hara H, Nagashima K, Adachi J, Boku N (2021) A Phase I study of pevonedistat plus capecitabine plus oxaliplatin in patients with advanced gastric cancer refractory to platinum (NCCH-1811). Future Sci OA 7:FSO721","journal-title":"Future Sci OA"},{"issue":"1","key":"4893_CR36","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1186\/s12935-022-02717-5","volume":"22","author":"P Su","year":"2022","unstructured":"Su P, Jiang L, Zhang Y, Yu T, Kang W, Liu Y, Yu J (2022) Crosstalk between tumor-associated macrophages and tumor cells promotes chemoresistance via CXCL5\/PI3K\/AKT\/mTOR pathway in gastric cancer. Cancer Cell Int 22(1):290","journal-title":"Cancer Cell Int"},{"issue":"4","key":"4893_CR37","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s12253-016-0066-5","volume":"22","author":"I Riquelme","year":"2016","unstructured":"Riquelme I, Tapia O, Espinoza JA, Leal P, Buchegger K, Sandoval A, Bizama C, Araya JC, Peek RM, Roa JC (2016) The Gene Expression Status of the PI3K\/AKT\/mTOR Pathway in Gastric Cancer Tissues and Cell Lines. Pathol Oncol research: POR 22(4):797\u2013805","journal-title":"Pathol Oncol research: POR"},{"key":"4893_CR38","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS, Morrison B, Stockwell BR (2012) Ferroptosis: An iron-dependent form of nonapoptotic cell death. Cell 149:1060\u20131072","journal-title":"Cell"},{"key":"4893_CR39","first-page":"5249","volume":"80","author":"MR Liu","year":"2020","unstructured":"Liu MR, Zhu WW, Qin Q, Su R, Xie WH, Li W, Guo ZY, Zhou L, Wang Q, Zhang C, He JJ, Wang (2020) H.AKT inhibition sensitizes cancer cells to ferroptosis via modulation of FOXO3a\u2013SLC7A11 signaling. Cancer Res 80:5249\u20135261","journal-title":"Cancer Res"},{"issue":"1","key":"4893_CR40","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00018-025-05812-8","volume":"17","author":"X Ding","year":"2025","unstructured":"Ding X, Cui L, Mi Y, Hu J, Cai Z, Tang Q, Yang L, Yang Z, Wang Q, Li H, Hou B, Liu Q, Zou Z, Chen Y (2025) Ferroptosis in cancer: revealing the multifaceted functions of mitochondria. Cell Mol Life Sci 17(1):277","journal-title":"Cell Mol Life Sci"},{"issue":"11","key":"4893_CR41","doi-asserted-by":"publisher","first-page":"4436","DOI":"10.4251\/wjgo.v16.i11.4436","volume":"15","author":"SL Li","year":"2024","unstructured":"Li SL, Wang PY, Jia YP, Zhang ZX, He HY, Chen PY, Liu X, Liu B, Lu L, Fu WH (2024) BIRC3 induces the phosphoinositide 3-kinase-Akt pathway activation to promote trastuzumab resistance in human epidermal growth factor receptor 2-positive gastric cancer. World J Gastrointest Oncol 15(11):4436\u20134455","journal-title":"World J Gastrointest Oncol"},{"key":"4893_CR42","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41568-019-0226-5","volume":"20","author":"BR Stockwell","year":"2020","unstructured":"Stockwell BR, Jiang X, Gu W (2020) Emerging mechanisms and therapeutic potential of ferroptosis in cancer. Nat Rev Cancer 20:57\u201370","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"4893_CR43","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12964-023-01421-9","volume":"22","author":"R Zhao","year":"2024","unstructured":"Zhao R, Hu Z, Zhang X, Huang S, Yu G, Wu Z, Yu W, Lu J, Ruan B (2024) The oncogenic mechanisms of the Janus kinase-signal transducer and activator of transcription pathway in digestive tract tumors. Cell communication signaling: CCS 22(1):68","journal-title":"Cell communication signaling: CCS"},{"issue":"8","key":"4893_CR44","doi-asserted-by":"publisher","first-page":"4147","DOI":"10.3390\/ijms23084147","volume":"23","author":"X Li","year":"2022","unstructured":"Li X, Pan K, Vieth M, Gerhard M, Li W, Mej\u00edas-Luque R (2022) JAK-STAT1 Signaling Pathway Is an Early Response to Helicobacter pylori Infection and Contributes to Immune Escape and Gastric Carcinogenesis. Int J Mol Sci 23(8):4147","journal-title":"Int J Mol Sci"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-026-04893-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00280-026-04893-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-026-04893-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T02:19:44Z","timestamp":1777429184000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00280-026-04893-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4893"],"URL":"https:\/\/doi.org\/10.1007\/s00280-026-04893-x","relation":{},"ISSN":["1432-0843"],"issn-type":[{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"assertion":[{"value":"19 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This animal study was approved by the Institutional Animal Care and Use Committee of the Zhejiang Centre of Laboratory Animals (approval number: ZJCLA-IACUC-20010059). All institutional and national guidelines for the care and use of laboratory animals were followed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent for publication"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial"}}],"article-number":"39"}}